# The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients

> **NCT03286712** · PHASE4 · COMPLETED · sponsor: **National Kidney and Transplant Institute, Philippines** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Kidney Disease
- Anemia
- Complication of Peritoneal Dialysis

## Interventions

- **DRUG:** Renogen

## Key facts

- **NCT ID:** NCT03286712
- **Lead sponsor:** National Kidney and Transplant Institute, Philippines
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-03
- **Final completion:** 2017-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03286712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03286712, "The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03286712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*